SS-31 and Cardiolipin Interactions: Mitochondrial Membrane Dynamics in Isolated Organelles
The inner mitochondrial membrane (IMM) is among the most protein-dense biological membranes in eukaryotic cells, and its structural integrity depends critically on the anionic phospholipid cardiolipin. Over the past decade, the Szeto-Schiller tetrapeptide SS-31 (D-Arg-2′,6′-dimethylTyr-Lys-Phe-NH2), also designated elamipretide, has emerged as a uniquely selective cardiolipin-binding compound that modulates membrane biophysics in isolated mitochondrial preparations. This review examines the current mechanistic understanding of SS-31-cardiolipin interactions and their downstream consequences for organelle-level respiratory function.
Disclaimer: This article is intended for informational and research purposes only. SS-31 and all compounds discussed herein are not intended for human or animal use.
Cardiolipin: The Architectural Phospholipid of the Inner Mitochondrial Membrane
Cardiolipin (CL) is a unique dimeric phospholipid synthesized exclusively in the IMM, where it constitutes approximately 15-20% of total phospholipid mass. Its distinctive four-acyl-chain structure generates an intrinsic negative curvature that is essential for stabilizing cristae junctions and maintaining the high membrane curvature required for efficient oxidative phosphorylation (Venkatraman & Budin, 2024). Within the IMM, CL molecules aggregate into microdomains or lipid rafts that serve as organizational platforms for respiratory chain complexes. When these cardiolipin rafts are disrupted, whether through peroxidation, enzymatic degradation, or genetic deficiency, cristae curvature collapses and the spatial organization of respiratory supercomplexes deteriorates.
The functional significance of CL extends beyond structural scaffolding. Cardiolipin directly interacts with and is required for optimal activity of electron transport chain (ETC) complexes I, III, and IV, as well as the F1F0-ATP synthase. Critically, CL mediates the assembly of individual respiratory complexes into higher-order supercomplexes (respirasomes), which channel electrons more efficiently and minimize reactive oxygen species (ROS) generation at complexes I and III. Studies in yeast lacking cardiolipin synthase demonstrated that approximately 90% of complexes III and IV existed as individual homodimers rather than supercomplexes, confirming the indispensable role of CL in supercomplex stabilization.
SS-31 belongs to a class of amphipathic tetrapeptides originally developed by Hazel Szeto and Peter Schiller. Its alternating aromatic-cationic motif (D-Arg-Dmt-Lys-Phe) enables selective partitioning into CL-enriched membranes through a combination of electrostatic interactions between the positively charged D-Arg and Lys residues and the anionic CL headgroup, and hydrophobic insertion of the 2′,6′-dimethyltyrosine (Dmt) and phenylalanine side chains into the acyl core of the bilayer.
Biophysical studies using model membranes and isolated mitochondria have established that SS-31 concentrates approximately 1,000- to 5,000-fold at the IMM surface despite its net positive charge (Mitchell et al., 2020). This accumulation is driven by cardiolipin binding density rather than the mitochondrial membrane potential (Delta Psi), distinguishing SS-31 from conventional lipophilic cations such as triphenylphosphonium (TPP+) conjugates. Quantitative binding analyses report a dissociation constant (KD) of approximately 2.9 micromolar for CL-containing bilayers, with binding affinity and lipid packing density directly proportional to surface charge density.
Nuclear magnetic resonance (NMR) and molecular dynamics simulations have revealed that SS-31 adopts an extended conformation in the membrane-bound state, in contrast to related analogs (SS-20, SPN10) that form compact reverse-turn structures (Mitchell et al., 2022). This structural distinction appears functionally significant: the extended conformation of SS-31 allows simultaneous engagement with multiple CL headgroups, promoting CL self-association and enhancing lateral packing within the IMM.
Modulation of Membrane Electrostatics and Physical Properties
A central mechanistic finding from recent biophysical work is that SS-31 modulates the surface electrostatic potential of CL-containing membranes. By neutralizing a fraction of the negative surface charge contributed by CL headgroups, SS-31 alters the distribution of ions and peripheral membrane proteins at the IMM interface (Mitchell et al., 2020). This electrostatic tuning has several downstream consequences relevant to organelle physiology:
Increased CL Self-Association and Microdomain Stability
SS-31 binding promotes tighter clustering of CL molecules into functional microdomains, reinforcing the lipid rafts that scaffold respiratory supercomplexes. Molecular simulations demonstrate that SS-31 decreases lateral diffusivity of lipids within the membrane while increasing lateral packing order, effects that collectively stabilize the high-curvature cristae architecture required for efficient electron transfer.
Enhancement of Membrane Curvature
The peptide’s ability to induce tighter curvatures in cristae membranes optimizes the spatial organization of respiratory supercomplexes, enhancing electron transfer efficiency and reducing the production of reactive oxygen species. This property has been directly visualized using serial block-face scanning electron microscopy (SBF-SEM), which generates three-dimensional reconstructions of cristae networks in isolated cardiac mitochondria (Allen et al., 2020).
Note: All peptide compounds referenced in this article are sold strictly for in vitro research. These materials are not approved for human or animal use.
One of the most consequential effects of SS-31 at the molecular level involves the cardiolipin-cytochrome c interaction. Under physiological conditions, cytochrome c is loosely tethered to the outer leaflet of the IMM through electrostatic interactions with CL, enabling its function as a mobile electron carrier between complexes III and IV. However, when CL undergoes peroxidation, the altered acyl chains disrupt this tethering and promote a conformational change in cytochrome c that converts it from an electron carrier into a peroxidase enzyme. This gain-of-function peroxidase activity generates lipid hydroperoxides that propagate further CL oxidation, creating a destructive feedforward cycle.
SS-31 interrupts this pathological cascade by stabilizing the native CL-cytochrome c interaction. By maintaining proper CL acyl chain packing around cytochrome c, SS-31 prevents the conformational switch to peroxidase activity while preserving electron carrying function (Szeto, 2014). In isolated mitochondria, this translates to a 30-50% reduction in mitochondrial ROS production, improved cytochrome c retention on the IMM, and enhanced electron flux through the ETC.
Protein Interaction Landscape in Isolated Organelles
Chemical cross-linking with mass spectrometry (XL-MS) applied to isolated mitochondria treated with biotinylated SS-31 has revealed a defined protein interaction landscape. Chavez et al. (2020) identified two principal clusters of SS-31-interacting proteins: components of the oxidative phosphorylation (OXPHOS) pathway, including subunits of complexes I, III, IV, and the F1F0-ATP synthase; and enzymes involved in 2-oxoglutarate metabolism and signaling. These interactions are consistent with SS-31 concentrating at the IMM surface through CL binding and subsequently engaging nearby protein complexes.
Functional validation using high-resolution respirometry in isolated mitochondria confirmed that biotinylated SS-31 improved oxygen consumption rates and reduced H2O2 production, indicating that the identified protein interactions are functionally relevant rather than nonspecific cross-linking artifacts.
Furthermore, studies in aged murine muscle mitochondria demonstrated that SS-31 improves ADP sensitivity by increasing uptake through the adenine nucleotide translocator (ANT), a CL-dependent IMM carrier protein (Pharaoh et al., 2023). This finding links CL stabilization directly to substrate-level regulation of OXPHOS flux.
Related mitochondria-targeting peptides such as MOTS-c and metabolic cofactors including NAD+ represent complementary research tools for investigating mitochondrial bioenergetic pathways. Similarly, Epithalon and GHK-Cu are studied for their roles in cellular maintenance processes that intersect with mitochondrial function.
Cristae Network Integrity and Supercomplex Stabilization
Three-dimensional electron microscopy studies have provided striking visual evidence for SS-31’s effects on cristae architecture in isolated cardiac mitochondria. Allen et al. (2020) used SBF-SEM to reconstruct cristae networks following ischemia-reperfusion injury in rat hearts and demonstrated that elamipretide treatment mitigated fragmentation of cristae networks, increased cristae connectivity, enhanced cristae networking, and improved mitochondrial density compared to untreated controls.
In a murine model of Barth syndrome, a genetic disorder caused by TAFAZZIN mutations that impair CL remodeling, Russo et al. (2024) showed that SS-31 treatment restored mitochondrial morphology in cardiac tissue by modulating proteins involved in mitochondrial dynamics and mitophagy. Cardiac mitochondria isolated from TAFAZZIN-knockdown mice exhibited abnormal ultrastructural membrane morphology, accumulation of vacuoles, pro-fission conditions, and defective mitophagy, all of which were ameliorated by SS-31 administration.
These findings converge on a model in which SS-31 stabilizes CL microdomains to maintain cristae curvature, which in turn preserves the spatial proximity of respiratory complexes required for efficient supercomplex function. In explanted failing human heart tissue, elamipretide treatment significantly improved complex I and complex IV activities as well as supercomplex-associated complex IV activity (Chatfield et al., 2019).
Disclaimer: The compounds discussed in this article are intended for laboratory research use only and are not for human consumption, therapeutic use, or self-administration.
Emerging Directions and Next-Generation Analogs
Structure-activity relationship studies have begun to define how modifications to the SS-31 tetrapeptide scaffold alter membrane binding properties and biological activity. Mitchell et al. (2022) demonstrated that side chain composition and positional register influence membrane partitioning, surface electrostatic modulation, and cellular efficacy. Novel SS-31 derivatives with substituted aromatic residues have shown enhanced anti-inflammatory activity and up to 42% greater ATP synthesis in rotenone-challenged neuronal cells compared to the parent compound (RSC Advances, 2024).
A comprehensive 2025 review by Sabbah et al. in Biomedicine & Pharmacotherapy synthesized recent advances in understanding elamipretide’s mechanism, emphasizing the shift from early ROS-scavenging models to a more nuanced framework centered on CL-dependent membrane electrostatic modulation and protein complex assembly. Similarly, Tung et al. (2025) provided an updated structural and pharmacological analysis covering the peptide’s therapeutic potential across multiple organ systems.
What is the primary molecular target of SS-31 in isolated mitochondria?
SS-31 selectively binds the anionic phospholipid cardiolipin on the inner mitochondrial membrane. This interaction is mediated by electrostatic attraction between the peptide’s cationic residues (D-Arg, Lys) and the CL headgroup, combined with hydrophobic insertion of aromatic side chains (Dmt, Phe) into the lipid bilayer. The binding affinity (KD approximately 2.9 micromolar) drives a 1,000- to 5,000-fold concentration of the peptide at the IMM surface.
How does SS-31 differ from conventional mitochondria-targeted antioxidants?
Unlike triphenylphosphonium (TPP+)-conjugated antioxidants that accumulate in the matrix driven by membrane potential, SS-31 localizes to the IMM surface through direct CL binding. Its mechanism extends beyond stoichiometric ROS scavenging to include catalytic modulation of membrane electrostatics, CL microdomain stabilization, and prevention of cytochrome c peroxidase conversion.
What role does cardiolipin peroxidation play in mitochondrial dysfunction?
Peroxidation of CL acyl chains disrupts CL microdomains, destabilizes cristae curvature, and triggers the conformational conversion of cytochrome c from an electron carrier to a peroxidase. This creates a feedforward cycle of lipid oxidation that dismantles respiratory supercomplexes and increases electron leak as ROS at complexes I and III.
How does SS-31 influence respiratory supercomplex assembly?
By stabilizing CL microdomains and promoting CL self-association within the IMM, SS-31 maintains the cristae architecture required for proper spatial organization of respiratory complexes I, III, and IV into supercomplexes (respirasomes). Studies in isolated cardiac mitochondria show improved supercomplex-associated complex IV activity following SS-31 treatment.
What structural features of SS-31 are critical for its cardiolipin-binding activity?
NMR and molecular dynamics studies indicate that the alternating aromatic-cationic motif and the extended membrane-bound conformation of SS-31 are essential for simultaneous engagement with multiple CL headgroups. The 2′,6′-dimethyl substitution on tyrosine enhances hydrophobic membrane insertion while the D-configuration of arginine confers protease resistance.
Has SS-31 been studied in genetic models of cardiolipin deficiency?
Yes. In TAFAZZIN-knockdown mice, a model of Barth syndrome characterized by impaired CL remodeling, SS-31 treatment restored cardiac mitochondrial morphology, reversed pro-fission conditions, and corrected defective mitophagy (Russo et al., 2024). These findings demonstrate efficacy even in the context of primary CL metabolic defects.
What analytical methods are used to study SS-31-protein interactions in isolated mitochondria?
Chemical cross-linking with mass spectrometry (XL-MS) using biotinylated SS-31 has identified specific protein interactors on the IMM. High-resolution respirometry (Oroboros O2k), transmission electron microscopy (TEM), serial block-face scanning electron microscopy (SBF-SEM), and fluorescence-based ROS assays are standard tools for characterizing functional and structural outcomes of SS-31 treatment in isolated organelle preparations.
References
Chavez JD, Tang X, Campbell MD, et al. Mitochondrial protein interaction landscape of SS-31. Proc Natl Acad Sci U S A. 2020;117(26):15363-15373. PubMed
Mitchell W, Ng EA, Tamucci JD, et al. The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action. J Biol Chem. 2020;295(21):7452-7469. PubMed
Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol. 2014;171(8):2029-2050. PubMed
Mitchell W, Tamucci JD, Ng EL, et al. Structure-activity relationships of mitochondria-targeted tetrapeptide pharmacological compounds. eLife. 2022;11:e75531. PubMed
Pharaoh G, Kamat V, Kannan S, et al. The mitochondrially targeted peptide elamipretide (SS-31) improves ADP sensitivity in aged mitochondria by increasing uptake through the adenine nucleotide translocator (ANT). Geroscience. 2023;45(6):3529-3548. PubMed
Allen ME, Pennington ER, Perry JB, et al. The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae networks following cardiac ischemia reperfusion in rats. Commun Biol. 2020;3(1):389. PubMed
Russo S, De Rasmo D, Rossi R, Signorile A, Lobasso S. SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome. Sci Rep. 2024;14:13655. PubMed
Chatfield KC, Sparagna GC, Chau S, et al. Elamipretide improves mitochondrial function in the failing human heart. JACC Basic Transl Sci. 2019;4(2):147-157. PubMed
Tung C, Varzideh F, Farroni E, et al. Elamipretide: A review of its structure, mechanism of action, and therapeutic potential. Int J Mol Sci. 2025;26(3):944. PubMed
Sabbah HN, Alder NN, Sparagna GC, et al. Contemporary insights into elamipretide’s mitochondrial mechanism of action and therapeutic effects. Biomed Pharmacother. 2025;187:118056. PubMed
Du X, Zeng Q, Luo Y, et al. Application research of novel peptide mitochondrial-targeted antioxidant SS-31 in mitigating mitochondrial dysfunction. Mitochondrion. 2024;75:101846. PubMed
Venkatraman K, Budin I. Cardiolipin remodeling maintains the inner mitochondrial membrane in cells with saturated lipidomes. J Lipid Res. 2024;65(8):100601. PubMed
Zhao C, Zhuang X, Gao J. Elamipretide: The first cardiolipin-directed mitochondrial therapeutic for Barth syndrome approved under accelerated approval. Drug Discov Ther. 2026;19(6):435-436. PubMed
Confused by FDA peptide categories? You’re not alone. In 2024, the FDA dropped a bombshell by reclassifying popular peptides into “Category 2” – essentially banning many from compounding pharmacies. This regulatory shift sent shockwaves through the peptide therapy community. Understanding FDA Category 2 is crucial for anyone involved in peptide research or therapy. Let’s break …
SS-31 and Cardiolipin Interactions: Mitochondrial Membrane Dynamics in Isolated Organelles
SS-31 and Cardiolipin Interactions: Mitochondrial Membrane Dynamics in Isolated Organelles
The inner mitochondrial membrane (IMM) is among the most protein-dense biological membranes in eukaryotic cells, and its structural integrity depends critically on the anionic phospholipid cardiolipin. Over the past decade, the Szeto-Schiller tetrapeptide SS-31 (D-Arg-2′,6′-dimethylTyr-Lys-Phe-NH2), also designated elamipretide, has emerged as a uniquely selective cardiolipin-binding compound that modulates membrane biophysics in isolated mitochondrial preparations. This review examines the current mechanistic understanding of SS-31-cardiolipin interactions and their downstream consequences for organelle-level respiratory function.
Disclaimer: This article is intended for informational and research purposes only. SS-31 and all compounds discussed herein are not intended for human or animal use.
Cardiolipin: The Architectural Phospholipid of the Inner Mitochondrial Membrane
Cardiolipin (CL) is a unique dimeric phospholipid synthesized exclusively in the IMM, where it constitutes approximately 15-20% of total phospholipid mass. Its distinctive four-acyl-chain structure generates an intrinsic negative curvature that is essential for stabilizing cristae junctions and maintaining the high membrane curvature required for efficient oxidative phosphorylation (Venkatraman & Budin, 2024). Within the IMM, CL molecules aggregate into microdomains or lipid rafts that serve as organizational platforms for respiratory chain complexes. When these cardiolipin rafts are disrupted, whether through peroxidation, enzymatic degradation, or genetic deficiency, cristae curvature collapses and the spatial organization of respiratory supercomplexes deteriorates.
The functional significance of CL extends beyond structural scaffolding. Cardiolipin directly interacts with and is required for optimal activity of electron transport chain (ETC) complexes I, III, and IV, as well as the F1F0-ATP synthase. Critically, CL mediates the assembly of individual respiratory complexes into higher-order supercomplexes (respirasomes), which channel electrons more efficiently and minimize reactive oxygen species (ROS) generation at complexes I and III. Studies in yeast lacking cardiolipin synthase demonstrated that approximately 90% of complexes III and IV existed as individual homodimers rather than supercomplexes, confirming the indispensable role of CL in supercomplex stabilization.
$55.00Original price was: $55.00.$50.00Current price is: $50.00.SS-31 Structure and Cardiolipin Binding Mechanism
SS-31 belongs to a class of amphipathic tetrapeptides originally developed by Hazel Szeto and Peter Schiller. Its alternating aromatic-cationic motif (D-Arg-Dmt-Lys-Phe) enables selective partitioning into CL-enriched membranes through a combination of electrostatic interactions between the positively charged D-Arg and Lys residues and the anionic CL headgroup, and hydrophobic insertion of the 2′,6′-dimethyltyrosine (Dmt) and phenylalanine side chains into the acyl core of the bilayer.
Biophysical studies using model membranes and isolated mitochondria have established that SS-31 concentrates approximately 1,000- to 5,000-fold at the IMM surface despite its net positive charge (Mitchell et al., 2020). This accumulation is driven by cardiolipin binding density rather than the mitochondrial membrane potential (Delta Psi), distinguishing SS-31 from conventional lipophilic cations such as triphenylphosphonium (TPP+) conjugates. Quantitative binding analyses report a dissociation constant (KD) of approximately 2.9 micromolar for CL-containing bilayers, with binding affinity and lipid packing density directly proportional to surface charge density.
Nuclear magnetic resonance (NMR) and molecular dynamics simulations have revealed that SS-31 adopts an extended conformation in the membrane-bound state, in contrast to related analogs (SS-20, SPN10) that form compact reverse-turn structures (Mitchell et al., 2022). This structural distinction appears functionally significant: the extended conformation of SS-31 allows simultaneous engagement with multiple CL headgroups, promoting CL self-association and enhancing lateral packing within the IMM.
Modulation of Membrane Electrostatics and Physical Properties
A central mechanistic finding from recent biophysical work is that SS-31 modulates the surface electrostatic potential of CL-containing membranes. By neutralizing a fraction of the negative surface charge contributed by CL headgroups, SS-31 alters the distribution of ions and peripheral membrane proteins at the IMM interface (Mitchell et al., 2020). This electrostatic tuning has several downstream consequences relevant to organelle physiology:
Increased CL Self-Association and Microdomain Stability
SS-31 binding promotes tighter clustering of CL molecules into functional microdomains, reinforcing the lipid rafts that scaffold respiratory supercomplexes. Molecular simulations demonstrate that SS-31 decreases lateral diffusivity of lipids within the membrane while increasing lateral packing order, effects that collectively stabilize the high-curvature cristae architecture required for efficient electron transfer.
Enhancement of Membrane Curvature
The peptide’s ability to induce tighter curvatures in cristae membranes optimizes the spatial organization of respiratory supercomplexes, enhancing electron transfer efficiency and reducing the production of reactive oxygen species. This property has been directly visualized using serial block-face scanning electron microscopy (SBF-SEM), which generates three-dimensional reconstructions of cristae networks in isolated cardiac mitochondria (Allen et al., 2020).
Note: All peptide compounds referenced in this article are sold strictly for in vitro research. These materials are not approved for human or animal use.
$55.00Original price was: $55.00.$50.00Current price is: $50.00.Inhibition of Cytochrome c Peroxidase Activity
One of the most consequential effects of SS-31 at the molecular level involves the cardiolipin-cytochrome c interaction. Under physiological conditions, cytochrome c is loosely tethered to the outer leaflet of the IMM through electrostatic interactions with CL, enabling its function as a mobile electron carrier between complexes III and IV. However, when CL undergoes peroxidation, the altered acyl chains disrupt this tethering and promote a conformational change in cytochrome c that converts it from an electron carrier into a peroxidase enzyme. This gain-of-function peroxidase activity generates lipid hydroperoxides that propagate further CL oxidation, creating a destructive feedforward cycle.
SS-31 interrupts this pathological cascade by stabilizing the native CL-cytochrome c interaction. By maintaining proper CL acyl chain packing around cytochrome c, SS-31 prevents the conformational switch to peroxidase activity while preserving electron carrying function (Szeto, 2014). In isolated mitochondria, this translates to a 30-50% reduction in mitochondrial ROS production, improved cytochrome c retention on the IMM, and enhanced electron flux through the ETC.
Protein Interaction Landscape in Isolated Organelles
Chemical cross-linking with mass spectrometry (XL-MS) applied to isolated mitochondria treated with biotinylated SS-31 has revealed a defined protein interaction landscape. Chavez et al. (2020) identified two principal clusters of SS-31-interacting proteins: components of the oxidative phosphorylation (OXPHOS) pathway, including subunits of complexes I, III, IV, and the F1F0-ATP synthase; and enzymes involved in 2-oxoglutarate metabolism and signaling. These interactions are consistent with SS-31 concentrating at the IMM surface through CL binding and subsequently engaging nearby protein complexes.
Functional validation using high-resolution respirometry in isolated mitochondria confirmed that biotinylated SS-31 improved oxygen consumption rates and reduced H2O2 production, indicating that the identified protein interactions are functionally relevant rather than nonspecific cross-linking artifacts.
Furthermore, studies in aged murine muscle mitochondria demonstrated that SS-31 improves ADP sensitivity by increasing uptake through the adenine nucleotide translocator (ANT), a CL-dependent IMM carrier protein (Pharaoh et al., 2023). This finding links CL stabilization directly to substrate-level regulation of OXPHOS flux.
Related mitochondria-targeting peptides such as MOTS-c and metabolic cofactors including NAD+ represent complementary research tools for investigating mitochondrial bioenergetic pathways. Similarly, Epithalon and GHK-Cu are studied for their roles in cellular maintenance processes that intersect with mitochondrial function.
Cristae Network Integrity and Supercomplex Stabilization
Three-dimensional electron microscopy studies have provided striking visual evidence for SS-31’s effects on cristae architecture in isolated cardiac mitochondria. Allen et al. (2020) used SBF-SEM to reconstruct cristae networks following ischemia-reperfusion injury in rat hearts and demonstrated that elamipretide treatment mitigated fragmentation of cristae networks, increased cristae connectivity, enhanced cristae networking, and improved mitochondrial density compared to untreated controls.
In a murine model of Barth syndrome, a genetic disorder caused by TAFAZZIN mutations that impair CL remodeling, Russo et al. (2024) showed that SS-31 treatment restored mitochondrial morphology in cardiac tissue by modulating proteins involved in mitochondrial dynamics and mitophagy. Cardiac mitochondria isolated from TAFAZZIN-knockdown mice exhibited abnormal ultrastructural membrane morphology, accumulation of vacuoles, pro-fission conditions, and defective mitophagy, all of which were ameliorated by SS-31 administration.
These findings converge on a model in which SS-31 stabilizes CL microdomains to maintain cristae curvature, which in turn preserves the spatial proximity of respiratory complexes required for efficient supercomplex function. In explanted failing human heart tissue, elamipretide treatment significantly improved complex I and complex IV activities as well as supercomplex-associated complex IV activity (Chatfield et al., 2019).
Disclaimer: The compounds discussed in this article are intended for laboratory research use only and are not for human consumption, therapeutic use, or self-administration.
Emerging Directions and Next-Generation Analogs
Structure-activity relationship studies have begun to define how modifications to the SS-31 tetrapeptide scaffold alter membrane binding properties and biological activity. Mitchell et al. (2022) demonstrated that side chain composition and positional register influence membrane partitioning, surface electrostatic modulation, and cellular efficacy. Novel SS-31 derivatives with substituted aromatic residues have shown enhanced anti-inflammatory activity and up to 42% greater ATP synthesis in rotenone-challenged neuronal cells compared to the parent compound (RSC Advances, 2024).
A comprehensive 2025 review by Sabbah et al. in Biomedicine & Pharmacotherapy synthesized recent advances in understanding elamipretide’s mechanism, emphasizing the shift from early ROS-scavenging models to a more nuanced framework centered on CL-dependent membrane electrostatic modulation and protein complex assembly. Similarly, Tung et al. (2025) provided an updated structural and pharmacological analysis covering the peptide’s therapeutic potential across multiple organ systems.
All SS-31 research compounds supplied by Oath Research are accompanied by third-party certificates of analysis verifying identity and purity.
$55.00Original price was: $55.00.$50.00Current price is: $50.00.Frequently Asked Questions
What is the primary molecular target of SS-31 in isolated mitochondria?
SS-31 selectively binds the anionic phospholipid cardiolipin on the inner mitochondrial membrane. This interaction is mediated by electrostatic attraction between the peptide’s cationic residues (D-Arg, Lys) and the CL headgroup, combined with hydrophobic insertion of aromatic side chains (Dmt, Phe) into the lipid bilayer. The binding affinity (KD approximately 2.9 micromolar) drives a 1,000- to 5,000-fold concentration of the peptide at the IMM surface.
How does SS-31 differ from conventional mitochondria-targeted antioxidants?
Unlike triphenylphosphonium (TPP+)-conjugated antioxidants that accumulate in the matrix driven by membrane potential, SS-31 localizes to the IMM surface through direct CL binding. Its mechanism extends beyond stoichiometric ROS scavenging to include catalytic modulation of membrane electrostatics, CL microdomain stabilization, and prevention of cytochrome c peroxidase conversion.
What role does cardiolipin peroxidation play in mitochondrial dysfunction?
Peroxidation of CL acyl chains disrupts CL microdomains, destabilizes cristae curvature, and triggers the conformational conversion of cytochrome c from an electron carrier to a peroxidase. This creates a feedforward cycle of lipid oxidation that dismantles respiratory supercomplexes and increases electron leak as ROS at complexes I and III.
How does SS-31 influence respiratory supercomplex assembly?
By stabilizing CL microdomains and promoting CL self-association within the IMM, SS-31 maintains the cristae architecture required for proper spatial organization of respiratory complexes I, III, and IV into supercomplexes (respirasomes). Studies in isolated cardiac mitochondria show improved supercomplex-associated complex IV activity following SS-31 treatment.
What structural features of SS-31 are critical for its cardiolipin-binding activity?
NMR and molecular dynamics studies indicate that the alternating aromatic-cationic motif and the extended membrane-bound conformation of SS-31 are essential for simultaneous engagement with multiple CL headgroups. The 2′,6′-dimethyl substitution on tyrosine enhances hydrophobic membrane insertion while the D-configuration of arginine confers protease resistance.
Has SS-31 been studied in genetic models of cardiolipin deficiency?
Yes. In TAFAZZIN-knockdown mice, a model of Barth syndrome characterized by impaired CL remodeling, SS-31 treatment restored cardiac mitochondrial morphology, reversed pro-fission conditions, and corrected defective mitophagy (Russo et al., 2024). These findings demonstrate efficacy even in the context of primary CL metabolic defects.
What analytical methods are used to study SS-31-protein interactions in isolated mitochondria?
Chemical cross-linking with mass spectrometry (XL-MS) using biotinylated SS-31 has identified specific protein interactors on the IMM. High-resolution respirometry (Oroboros O2k), transmission electron microscopy (TEM), serial block-face scanning electron microscopy (SBF-SEM), and fluorescence-based ROS assays are standard tools for characterizing functional and structural outcomes of SS-31 treatment in isolated organelle preparations.
References
2 Day FAST Shipping
99%+ Purity Tests
Ships from Gilbert Arizona
USA Lab Tested
Free bacteriostatic water with every order.
Related Posts
What is FDA Category 2 for Peptides?
Confused by FDA peptide categories? You’re not alone. In 2024, the FDA dropped a bombshell by reclassifying popular peptides into “Category 2” – essentially banning many from compounding pharmacies. This regulatory shift sent shockwaves through the peptide therapy community. Understanding FDA Category 2 is crucial for anyone involved in peptide research or therapy. Let’s break …